» Articles » PMID: 39203950

Building Quality Control for Molecular Assays in the Global Measles and Rubella Laboratory Network

Overview
Date 2024 Aug 29
PMID 39203950
Authors
Affiliations
Soon will be listed here.
Abstract

More than 100 laboratories in the World Health Organization Global Measles and Rubella Laboratory Network (GMRLN) perform nucleic acid-based methods for case confirmation of measles or rubella infections and/or strain surveillance (genotyping). The quality of laboratory data is critical to ensure that diagnostic results and country reports to regional verification committees are based on accurate data. A molecular External Quality Assurance (mEQA) program was initiated by the US-CDC in 2014 to evaluate the performance of laboratories in the network. The inclusion of testing for measles and rubella viruses, with a focus on detection and genotyping, plus the diversity of assays and platforms employed required a flexible and comprehensive proficiency testing program. A stepwise introduction of new evaluation criteria gradually increased the stringency of the proficiency testing program, while giving laboratories time to implement the required changes. The mEQA program plays an important role in many processes in the GMRLN, including informing plans for the training of laboratory staff, access to reagents, and the submission of sequence data to global databases. The EQA program for Local Public Health Institutes in Japan is described as an example for national mEQA programs. As more laboratories initiate molecular testing, the mEQA will need to continue to expand and to adapt to the changing landscape for molecular testing.

References
1.
Schulz H, Hiebert J, Frost J, McLachlan E, Severini A . Optimisation of methodology for whole genome sequencing of Measles Virus directly from patient specimens. J Virol Methods. 2021; 299:114348. DOI: 10.1016/j.jviromet.2021.114348. View

2.
Bankamp B, Kim G, Hart D, Beck A, Ben Mamou M, Penedos A . Global Update on Measles Molecular Epidemiology. Vaccines (Basel). 2024; 12(7). PMC: 11281501. DOI: 10.3390/vaccines12070810. View

3.
Abernathy E, Chen M, Bera J, Shrivastava S, Kirkness E, Zheng Q . Analysis of whole genome sequences of 16 strains of rubella virus from the United States, 1961-2009. Virol J. 2013; 10:32. PMC: 3574052. DOI: 10.1186/1743-422X-10-32. View

4.
Potdar V, Vijay N, Vipat V, Jadhav S, Gupta N, Aggarwal N . External quality assessment for laboratories in pan-India ILI/SARI surveillance for simultaneous detection of influenza virus and SARS-CoV-2. Front Public Health. 2023; 11:1274508. PMC: 10679675. DOI: 10.3389/fpubh.2023.1274508. View

5.
Gardy J, Naus M, Amlani A, Chung W, Kim H, Tan M . Whole-Genome Sequencing of Measles Virus Genotypes H1 and D8 During Outbreaks of Infection Following the 2010 Olympic Winter Games Reveals Viral Transmission Routes. J Infect Dis. 2015; 212(10):1574-8. DOI: 10.1093/infdis/jiv271. View